Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: Potential role of insulin

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 37

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

355

HTML

2912

Tables (1-5)

242

Sum=3509

Oct 7, 2008 (publication date) through Feb 6, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Oct 7, 2008; 14(37): 5695-5700
Published online Oct 7, 2008. doi: 10.3748/wjg.14.5695

Table 4 Type of therapy with oral antidiabetic agents in HCC patients and controls with DM2

	Number of subjects	Diet with or without metformin N° cases (%)	Sulfonylureas with or without metformin N° cases (%)	P
Total
HCC	88	14 (15.9)	74 (84.1)	0.04
Controls	48	15 (31.2)	33 (68.8)
Males
HCC	75	12 (16.0)	63 (84.0)	0.049
Controls	41	13 (31.7)	28 (68.3)
Females
HCC	13	2 (15.4)	11 (84.6)	0.5
Controls	7	2 (28.6)	5 (71.4)

Citation: Donadon V, Balbi M, Casarin P, Vario A, Alberti A. Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: Potential role of insulin. World J Gastroenterol 2008; 14(37): 5695-5700
URL: https://www.wjgnet.com/1007-9327/full/v14/i37/5695.htm
DOI: https://dx.doi.org/10.3748/wjg.14.5695